The medical and anaesthetic management of acromegalic patients undergoing maxillo-facial surgery.
Three acromegalic patients are described in whom successful surgical correction of the prognathism was performed. No immediate post-operative upper respiratory tract obstruction nor cardiac dysrrhythmias occurred as have been reported in previously recorded cases. It is suggested that particular attention be paid to the recognition and prevention of these complications. In addition we believe that initial treatment should be directed to the achievement of as near normal growth hormone levels as possible for at least a year before maxillo-facial surgery so that there may be maximal soft tissue regression and reduction of airway hazards and cardiac embarrassment.
D000172:Acromegaly / Q000097:blood / Q000628:therapy*; D000328:Adult; D000766:Anesthesia, Dental / Q000379:methods*; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D008297:Male; D010027:Osteotomy / Q000379:methods; D011229:Preanesthetic Medication; D011378:Prognathism / Q000601:surgery*
D013006:Growth Hormone